These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 31164462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH.
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [Abstract] [Full Text] [Related]

  • 3. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
    Loiko V, Wagener J.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
    Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, Lass-Flörl C.
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3504-11. PubMed ID: 18644959
    [Abstract] [Full Text] [Related]

  • 8. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
    Staab JF, Kahn JN, Marr KA.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4992-8. PubMed ID: 20855747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Echinocandin Resistance in Aspergillus fumigatus Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions.
    Satish S, Perlin DS.
    Microbiol Insights; 2019 Dec; 12():1178636119897034. PubMed ID: 35185336
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.
    Rocha EM, Garcia-Effron G, Park S, Perlin DS.
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4174-6. PubMed ID: 17724146
    [Abstract] [Full Text] [Related]

  • 14. Aspergillus fumigatus Transcription Factors Involved in the Caspofungin Paradoxical Effect.
    Valero C, Colabardini AC, Chiaratto J, Pardeshi L, de Castro PA, Ferreira Filho JA, Silva LP, Rocha MC, Malavazi I, Costa JH, Fill T, Barros MH, Wong SSW, Aimanianda V, Wong KH, Goldman GH.
    mBio; 2020 Jun 16; 11(3):. PubMed ID: 32546620
    [Abstract] [Full Text] [Related]

  • 15. Aspergillus fumigatus devoid of cell wall β-1,3-glucan is viable, massively sheds galactomannan and is killed by septum formation inhibitors.
    Dichtl K, Samantaray S, Aimanianda V, Zhu Z, Prévost MC, Latgé JP, Ebel F, Wagener J.
    Mol Microbiol; 2015 Feb 16; 95(3):458-71. PubMed ID: 25425041
    [Abstract] [Full Text] [Related]

  • 16. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point-Mutation-Mediated Resistance.
    Jospe-Kaufman M, Ben-Zeev E, Mottola A, Dukhovny A, Berman J, Carmeli S, Fridman M.
    Angew Chem Int Ed Engl; 2024 Feb 26; 63(9):e202314728. PubMed ID: 38161189
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
    Katiyar SK, Alastruey-Izquierdo A, Healey KR, Johnson ME, Perlin DS, Edlind TD.
    Antimicrob Agents Chemother; 2012 Dec 26; 56(12):6304-9. PubMed ID: 23027185
    [Abstract] [Full Text] [Related]

  • 20. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
    Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN.
    Diagn Microbiol Infect Dis; 2011 Jan 26; 69(1):45-50. PubMed ID: 21146713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.